Bio-Connect
IHC-P analysis of human placenta tissue using GTX87757 APOBEC3D + APOBEC3F antibody. The picture on the right is blocked with the synthesized peptide.
IHC-P analysis of human placenta tissue using GTX87757 APOBEC3D + APOBEC3F antibody. The picture on the right is blocked with the synthesized peptide.
IHC-P analysis of human placenta tissue using GTX87757 APOBEC3D + APOBEC3F antibody. The picture on the right is blocked with the synthesized peptide.

APOBEC3D + APOBEC3F antibody

GTX87757
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Monkey
TargetAPOBEC3D
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    APOBEC3D + APOBEC3F antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500~1:1000. IHC-P: 1:50~1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID140564
  • Target name
    APOBEC3D
  • Target description
    apolipoprotein B mRNA editing enzyme catalytic subunit 3D
  • Target synonyms
    A3D; A3DE; APOBEC3DE; APOBEC3E; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3E pseudogene; ARP6; DNA dC->dU-editing enzyme APOBEC-3D; probable DNA dC->dU-editing enzyme APOBEC-3D
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ8IUX4
  • Protein Name
    DNA dC->dU-editing enzyme APOBEC-3F
  • Reactivity
    Human, Monkey
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • A Conserved uORF Regulates APOBEC3G Translation and Is Targeted by HIV-1 Vif Protein to Repress the Antiviral Factor. Libre C et al., 2021 Dec 22, Biomedicines
    Read more